289
VIEW CASE STUDY ARTICLES HERE
Next Case Study --->
Changing gears a bit … my first article in the USA edition almost two years ago clearly stated that the consolidation curve cannot be avoided and recently stated 2018 will be like nothing we have seen before. In the first month we have ACB-CMED and APH-NUU.
We also know that third party validation is always the best attestation and this article on M&A does just that. Just as this Seeking Alpha piece is in sync with our sentiment on the dot-com comparison. After the fact third part validation always provides comfort to our readers that our anticipatory views are spot on.
Neutrisci International Inc (TSXV:NU;OTC: NRXCF) has also been a staple in these pages and their recent announcement cannot go un-noticed with respect to Scientus Pharma. We always emphasize the importance of connecting the dots. From past issues, we know Aphria is invested in Scientus Pharma and that Dragon’s Den Arlene Dickinson was a Board Member of both Neutrisci and Aphria. Dots or a coincidence and if you read this month’s article then you know that a coincidence are events that are “apparently” unrelated.
The New Solactive Emerging Marijuana Growers Index ETF will be trading soon – keep an eye out!
And remember … all of our content is for information and discussion purposes only and is not ever considered investment advice or recommendations of any kind. You and you alone are responsible for your investment decisions.